According to Nautilus Biotechnology's latest financial reports the company's current EPS (TTM) is -$0.49. In 2022 the company made an earnings per share (EPS) of -$0.47 an increase over its 2021 EPS that were of -$0.51.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.49 | 4.26% |
2022 | -$0.47 | -7.44% |
2021 | -$0.51 |